INT IMMUNOPHARMACOL 润色咨询

INTERNATIONAL IMMUNOPHARMACOLOGY

出版年份:2001 年文章数:5633 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:4.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=4e117057, cover=https://img.medsci.cn/images/journal/cover/2021/eCH_202109271315199220.jpg, fullname=INTERNATIONAL IMMUNOPHARMACOLOGY, abbr=INT IMMUNOPHARMACOL, pyear=2001, frequence=Monthly, articleNumbers=5633, citedSelf2015=4.7, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均1.95月, reviewFee=0.0, pageFee=2580.0, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1567-5769, greenSci=https://www.greensci.net/search?kw=1567-5769, scijournal=https://www.scijournal.org/impact-factor-of-INT-IMMUNOPHARMACOL.shtml, medsciHotlightString=null, medsciHotlightRealtime=62.21, medsciHotlight=44.964, medsciHotlight5year=45.5313, citescore=5.6, hIndex=112, impactFactor=5.6, orgnization=Elsevier, orgnizationUrl=http://www.elsevier.com, country=Netherlands, countryCn=荷兰, isOa=3, isOaString=部分OA, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学 3区, smallclassCas=医学 2 区, website=https://www.elsevier.com/wps/find/journaldescription.cws_home/621330/description#description, websiteHits=43139, guideForAuthor=https://www.elsevier.com/journals/international-immunopharmacology/1567-5769/guide-for-authors, guideForAuthorHits=3438, submitWebsite=https://ees.elsevier.com/intimp/, submitWebsiteHits=27659, content=Published by Elsevier Science. ISSN: 1567-5769.<br><br>Merger of International Journal of Immunopharmacology and Immunopharmacology. International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome. The subject material appropriate for submission includes: Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders. Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state. Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses. Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action. Agents that activate genes or modify transcription and translation within the immune response. Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active. Production, function and regulation of cytokines and their receptors. Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions. Studies on the nature and function of drug and hormone receptors on lymphocytes and other cells in the immune system. Studies of cell-derived or humoral factors that modify the immune system causing cytotoxicity, inducing antibody production and mediating inflammatory responses. The development of immunologically based assays and their application to disease, including assays for drugs, hormones, cyclic nucleotides, tumor antigens, etc., totalCites=31549, brief=INT IMMUNOPHARMACOL杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=免疫学" >免疫学</a></strong>”子行业的偏低级别杂志, articleType=绝大部分收录论著,也接收少量其它类型文章, medsciHeat=<span style="color: #ff0000;"><span style="color: #ff00ff;">洋红</span></span>, medsciComment=INT IMMUNOPHARMACOL是不错的SCI杂志,中国人文章也较容易被接收,竞争相对来说,也不算太残酷,强烈建议试试他们。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=4e117057'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=205, tagName=免疫, createdHits=42), ImpactFactorTagDto(id=1660, tagName=炎症, createdHits=35), ImpactFactorTagDto(id=27394, tagName=药理学, createdHits=14), ImpactFactorTagDto(id=10874, tagName=药理, createdHits=13), ImpactFactorTagDto(id=57838, tagName=生信, createdHits=8), ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=8), ImpactFactorTagDto(id=17994, tagName=细胞因子, createdHits=7), ImpactFactorTagDto(id=120, tagName=免疫学, createdHits=6), ImpactFactorTagDto(id=20213, tagName=肿瘤免疫, createdHits=4), ImpactFactorTagDto(id=4449, tagName=炎症反应, createdHits=3), ImpactFactorTagDto(id=438, tagName=胃癌, createdHits=3), ImpactFactorTagDto(id=43474, tagName=单体成分药物, createdHits=3), ImpactFactorTagDto(id=137, tagName=药物, createdHits=3), ImpactFactorTagDto(id=41490, tagName=中药单体, createdHits=3), ImpactFactorTagDto(id=1246, tagName=免疫治疗, createdHits=3), ImpactFactorTagDto(id=5209, tagName=炎症因子, createdHits=3), ImpactFactorTagDto(id=198, tagName=口腔, createdHits=2), ImpactFactorTagDto(id=41090, tagName=毒理, createdHits=2), ImpactFactorTagDto(id=57141, tagName=药物单体, createdHits=2), ImpactFactorTagDto(id=104904, tagName=基础药理, createdHits=2), ImpactFactorTagDto(id=159, tagName=中草药, createdHits=2), ImpactFactorTagDto(id=614, tagName=神经, createdHits=2), ImpactFactorTagDto(id=11, tagName=中药, createdHits=2), ImpactFactorTagDto(id=313, tagName=临床, createdHits=2), ImpactFactorTagDto(id=43232, tagName=免疫药理, createdHits=2), ImpactFactorTagDto(id=3399, tagName=NAFLD, createdHits=2), ImpactFactorTagDto(id=579, tagName=疫苗, createdHits=1), ImpactFactorTagDto(id=31388, tagName=兽医, createdHits=1), ImpactFactorTagDto(id=108091, tagName=免疫毒理学, createdHits=1), ImpactFactorTagDto(id=1999, tagName=细胞死亡, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=3.09), GetImpactFactorCiteScoreListResponse(year=2017, citescore=3.16), GetImpactFactorCiteScoreListResponse(year=2018, citescore=3.32), GetImpactFactorCiteScoreListResponse(year=2019, citescore=5.1), GetImpactFactorCiteScoreListResponse(year=2020, citescore=5.6)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=54.434), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=58.886), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=57.774), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=58.503), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=62.21)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmacology , rank=71/300), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Immunology and Allergy , rank=56/188), GetImpactFactorCiteScoreGradeResponse(smallClass=Immunology and Microbiology - Immunology , rank=70/198)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=IMMUNOLOGY, rank=Q3), GetImpactFactorCiteScoreGradeResponse(smallClass=PHARMACOLOGY & PHARMACY, rank=Q2)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1567-5769[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=INTERNATIONAL IMMUNOPHARMACOLOGY[ta], article_number=938, article_number_cn=676, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
INT IMMUNOPHARMACOL/INTERNATIONAL IMMUNOPHARMACOLOGY
ISSN
1567-5769
影响指数话题
预警等级
MedSci期刊指数
62.21 (MedSci实时期刊指数) | 45.5313 (5年期刊指数)
CiteScore值
5.6
h-index
112
h5-median
暂无数据
出版社/管理机构
杂志由 Elsevier 出版或管理
出版国家/地区
Netherlands 荷兰
出版周期
Monthly
出版年份
2001
是否OA
部分OA
被收录情况
Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews
JCR分区
IMMUNOLOGY Q3
PHARMACOLOGY & PHARMACY Q2
中科院分区
大类:医学 3区
小类:医学 2 区